The Role of Th17-Related Cytokines in Atopic Dermatitis
Open accessThe DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Abstract
T helper-17 (Th17) cells, which mainly produce IL-17, are associated with development of various autoimmune diseases such as rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, and psoriasis. IL-17 and related cytokines are therapeutic targets of these diseases. In atopic dermatitis (AD), Th2 cytokines such as IL-4 and IL-13 are regarded to be the main player of the disease; however, Th17 cytokines are also expressed in AD skin lesions. Expression of IL-22 rather than IL-17 is predominant in AD skin, which is contrary to cytokine expression in psoriasis skin. Relatively low IL-17 expression in AD skin can induce relatively low antimicrobial peptide expression, which may be a reason why bacterial infection is frequently seen in AD patients. Failure of clinical trials for investigating the efficacy of anti-IL-12/23 p40 in AD has suggested that IL-17 expressed in skin lesions should not be the main player but a bystander responding to barrier dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Proliferation of epidermal cells, AMP expression, vascular formation, and infiltration of Th17, neutrophils, and macrophages, commonly seen in wounded skin and in psoriasis skin. We sometimes experience fungal infection in patients treated with anit-IL7A or anti-IL17 receptor A antibody. Considering that Th17 cytokines are expressed in various skin diseases with barrier dysfunction and that antibodies against IL-12/IL-23p40 or IL-17A are not effective for AD, IL-17 and its related cytokine expression can be regarded as a common defense mechanism in the skin. Relatively low AMP expression leads to a higher risk of infection seen in AD and CTCL [77,78]. Targeting the Th17 cytokine has been successful for psoriasis, but may not be always the case in other skin diseases.](https://figures.cochat.ai/paper-figures/ed84282be6714f7887f1a44756b5fdc2/the-role-of-th17-related-cytokines-in-atopic-dermatitis-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upregulation of these receptors by PAHs can lead to disruption of the skin barrier and skewing of the immune response towards a Th2 phenotype, which is central to the development and progression of AD [23–25].”
From The Burden of Air Pollution on Skin Health: a Brief Report and Call to Action (2024) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 1×
“Th17 cells, which are different from Th1 or Th2 cells, produce IL-17, IL-17F, and IL-22 as well as IL-21 [21].”
BackgroundDefensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066 · cited 1×
“IL-17 also increases production of antimicrobial peptides (AMPs), which are part of the innate immune response and are found among all classes of life [30,31].”
BackgroundHuman epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183 · cited 4×
“The intrinsic type is characterized by the lower expression of IL-4, IL-5, and IL-13, and the higher expression of IFN-γ.”
BackgroundInfluentialLeonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Blauvelt, A., de Bruin-Weller, M., Gooderham, M., Cather, J. C., Weisman, J., Pariser, D., Simpson, E. L., Papp, K. A., Hong, H. C.-H., Rubel, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31191-1 · Cited by 1,261 · cited 2×
“Cytokines Clinical Response References IL-17A Worsening of dermatitis [57–59] IL-12/23p40 No effect in clinical trial [55,56] IL-22 Effective for some patients [60,61] IL-4/13 Very effective [68]”
BackgroundSonnenberg, G. F., Fouser, L. A., & Artis, D. (2011) · Nature Immunology · doi:10.1038/ni.2025 · Cited by 1,044 · cited 2×
“IL-22, which is another cytokine expressed by Th17, enhances AMP production together with IL-17 [31].”
BackgroundA role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130351 · Cited by 979
Jovanović, D., Battista, J. A. D., Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Martel‐Pelletier, J. (1998) · PubMed · Cited by 973
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Research works printed but not linked: 1
- Furue, 2019, Pathogenesis of atopic dermatitis: CurrentpParadigm, Iran. J. Immunol., 16, 97
Cited by
JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
Huang, I.-H., Chung, W.-H., Wu, P.-C., & Chen, C.-B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1068260 · Cited by 329
“These cytokines promote cell proliferation and macrophage infiltration into damaged skin and stimulate eosinophils to secrete profibrotic cytokines (29).”
BackgroundSkin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties
Baker, P., Huang, C., Radi, R., Moll, S. B., Jules, E., & Arbiser, J. L. (2023) · Cells · doi:10.3390/cells12232745 · Cited by 192
“IL-17 is expressed in atopic dermatitis lesions in relatively low concentrations [96].”
BackgroundExploring the Role of Staphylococcus aureus in Inflammatory Diseases
Chen, H., Zhang, J., He, Y., Lv, Z., Liang, Z., Chen, J., Li, P., Liu, J., Yang, H., Tao, A., et al. (2022) · Toxins · doi:10.3390/toxins14070464 · Cited by 179
Meng, J., Li, Y., Fischer, M. J. M., Steinhoff, M. S., Chen, W., & Wang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696784 · Cited by 117
Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis
Kader, H. A., Azeem, M., Jwayed, S. A., Al-Shehhi, A., Tabassum, A., Ayoub, M. A., Hetta, H. F., Waheed, Y., Iratni, R., Aldhaheri, A., et al. (2021) · Cells · doi:10.3390/cells10061392 · Cited by 105
Metadata
- Authors
- Sugaya, M.
- Affiliations
- International University of Health and Welfare Ichikawa Medical Center (JP)
- Corresponding author
- Sugaya, Makoto
- ORCID
- Sugaya, Makoto
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-15
- Volume
- 21
- Issue
- 4
- Pages
- 1314
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7072946
- OpenAlex
- W3006169882
- Semantic Scholar
- 1393156b84cfca45fd4122ed4220e8af97991f3b
- Cited by
- 204
- References
- 84
- Citations by year
- 2026: 18 · 2025: 28 · 2024: 48 · 2023: 32 · 2022: 42 · 2021: 23 · 2020: 12
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- atopic dermatitis, Th17 cells, IL-17, IL-22, Th2 cytokines, IL-4, IL-13, antimicrobial peptides, bacterial skin infections, skin barrier dysfunction, IL-12/23p40, psoriasis
- MeSH terms
- Interleukin-22, Dermatitis, Atopic, Humans, Interleukins, Skin, Keratinocytes, Interleukin-4, Cytokines, Interleukin-13, Interleukin-17, Antimicrobial Cationic Peptides, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Role of Th17-Related Cytokines in Atopic Dermatitis. https://app.cochat.ai/papers/10.3390/ijms21041314
- The paper
- Sugaya, M. (2020). The Role of Th17-Related Cytokines in Atopic Dermatitis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21041314
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.